These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455 [TBL] [Abstract][Full Text] [Related]
6. PD1 Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma. Liu F; Liu W; Sanin DE; Jia G; Tian M; Wang H; Zhu B; Lu Y; Qiao T; Wang X; Shi Y; Wu D Oncoimmunology; 2020; 9(1):1746573. PubMed ID: 32426177 [TBL] [Abstract][Full Text] [Related]
8. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors. Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral CD8 Virassamy B; Caramia F; Savas P; Sant S; Wang J; Christo SN; Byrne A; Clarke K; Brown E; Teo ZL; von Scheidt B; Freestone D; Gandolfo LC; Weber K; Teply-Szymanski J; Li R; Luen SJ; Denkert C; Loibl S; Lucas O; Swanton C; Speed TP; Darcy PK; Neeson PJ; Mackay LK; Loi S Cancer Cell; 2023 Mar; 41(3):585-601.e8. PubMed ID: 36827978 [TBL] [Abstract][Full Text] [Related]
10. Single-cell analysis reveals HBV-specific PD-1 Liu L; Liu J; Li P; Luo J; Qin R; Peng Q; Li B; Wei X; Wang T; Shi H; Wang MD; Li C; Fang W; Chen W; Xu X; Yang T; Yin W; Zeng X J Exp Clin Cancer Res; 2023 Jun; 42(1):152. PubMed ID: 37353792 [TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC. Shi J; Li G; Liu L; Yuan X; Wang Y; Gong M; Li C; Ge X; Lu S Front Immunol; 2023; 14():1166052. PubMed ID: 37077914 [TBL] [Abstract][Full Text] [Related]
12. Prognostic values of tissue-resident CD8 Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870 [TBL] [Abstract][Full Text] [Related]
13. Functional Heterogeneity of CD4 Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P Front Immunol; 2018; 9():2654. PubMed ID: 30505306 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive profile of TCF1 Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298 [TBL] [Abstract][Full Text] [Related]
15. 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8 Kim HD; Park S; Jeong S; Lee YJ; Lee H; Kim CG; Kim KH; Hong SM; Lee JY; Kim S; Kim HK; Min BS; Chang JH; Ju YS; Shin EC; Song GW; Hwang S; Park SH Hepatology; 2020 Mar; 71(3):955-971. PubMed ID: 31353502 [TBL] [Abstract][Full Text] [Related]
16. TREM2 Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359 [TBL] [Abstract][Full Text] [Related]
17. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J Front Immunol; 2023; 14():1137025. PubMed ID: 37006257 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel CD8 Liu K; Liu J; Zhang X; Liu D; Yao W; Bu Y; Chen B BMC Cancer; 2023 Dec; 23(1):1185. PubMed ID: 38049741 [TBL] [Abstract][Full Text] [Related]
19. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8 Chen H; Li Z; Qiu L; Dong X; Chen G; Shi Y; Cai L; Liu W; Ye H; Zhou Y; Ouyang J; Cai Z; Liu X J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113894 [TBL] [Abstract][Full Text] [Related]
20. PD-1 Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]